Report : North America Outpatient Central Fulfillment Market Forecast to 2030 - Regional Analysis - by Product Type (Automated Medication Dispensing Systems, Automated Packaging and Labelling Systems, Automated Tabletop Counters, Automated Storage and Retrieval Systems, and Others) and End User (Hospital Pharmacies, Retail Pharmacies, and Mail-Order Pharmacies)
At 11.0% CAGR, North America Outpatient Central Fulfillment Market is Projected to be Worth US$ 350.50 Million by 2030, says Business Market Insights
According to Business Market Insights’ research, the North America outpatient central fulfillment market was valued at US$ 152.56 million in 2022 and is expected to reach US$ 350.50 million by 2030, registering a CAGR of 11.0% from 2022 to 2030. Growth strategies by companies and use of Artificial Intelligence and risk of medication errors is among the critical factors attributed to the North America outpatient central fulfillment market expansion.
The companies operating in the outpatient central fulfillment market are focused on increasing their market share worldwide through organic and inorganic growth strategies. For instance, Capsa Healthcare, headquartered in Portland, Oregon, the US, is focused on developing medication carts, computer carts, medical carts, wall-mounted workstations, and prescription tablet counters. In February 2020, US-based Omnicell, Inc. partnered with Geisinger, one of the leading players in medication, supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions. Under this six-year source agreement with Omnicell, Geisinger would employ Omnicell XT Automated Dispensing Systems to help improve nurse-pharmacy workflows as well as medication safety and security. In January 2020, ARxIUM collaborated with Stäubli for its TX-60L UL robot to enhance the effectiveness of pharmacy operations by improving the safety and accuracy of IV admixture compounding. Hospital pharmacies use ARxIUM’s RIVA fully automated IV compounding system to prepare IV syringes and bags, and it is designed to confer patient safety by automating the preparation process.
Artificial intelligence (AI) has brought significant evolution in the healthcare sector. The technology complements the deployment of robotics in drug and medicine businesses. In addition, it can potentially assist pharmacists and clinical personnel in identifying problems such as potentially harmful drug interactions; and cross-verifying patient data, drug–disease contraindications, drug–drug interactions, improper dosages, and drug dosage repetition more effectively than ever. AI can provide real-time guidance when prescribing, dispensing, and administering medicine. It would help provide personalized medicines to patients, aiding pharmacy management. AI in medicine dispensing will enhance the efficiency of automated dispensing cabinets; pill dispensers; and other components such as alarm modules and speakers. Thus, strategic developments and AI integration would lead to new growth trends in the outpatient central fulfillment market in the coming years.
On the contrary, high capital requirements and problems associated with automation system operations hurdles the growth of North America outpatient central fulfillment market.
Based on product type, the North America outpatient central fulfillment market is categorized into automated medication dispensing systems, automated packaging and labelling systems, automated tabletop counters, automated storage and retrieval systems, and others. The automated medication dispensing systems segment held 33.1% share of North America outpatient central fulfillment market in 2022, amassing US$ 50.47 million. It is projected to garner US$ 121.86 million by 2030 to expand at 11.6% CAGR during 2022–2030.
In terms of end user, the North America outpatient central fulfillment market is segmented into hospital pharmacies, retail pharmacies, and mail-order pharmacies. The hospital pharmacies segment held 54.9% share of North America outpatient central fulfillment market in 2022, amassing US$ 83.81 million. It is projected to garner US$ 199.47 million by 2030 to expand at 11.4% CAGR during 2022–2030.
Based on country, the North America outpatient central fulfillment market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 84.9% share of North America outpatient central fulfillment market in 2022. It was assessed at US$ 129.54 million in 2022 and is likely to hit US$ 300.42 million by 2030, exhibiting a CAGR of 11.1% during 2022–2030.
Key players operating in the North America outpatient central fulfillment market are Tension Envelope Corp, ScriptPro LLC, Cardinal Health Inc, Omnicell Inc, Becton Dickinson and Co, RxSafe LLC, Custom Health Inc, Capsa Solutions LLC, Surescripts LLC, and McKesson Corp, among others.
- In March 2022, Tension Corporation acquired the print division assets of Intellus Direct. This acquisition expanded Tension's presence in the high-end direct mail and print marketing space while consolidating its supply chain by vertically integrating the print and envelope converting operations that support Tension's direct mail and print marketing offerings.
- In June 2023, Cardinal Health Inc has announced its plans to expand a new distribution center in Greenville, South Carolina. The new center area will support its at-Home Solutions business, which supplies home healthcare medical supplies and serves people with chronic and serious health conditions in the United States. The new facility center will be the company’s second distribution center to feature AutoStore empowered by Swisslog, the market's fastest order fulfillment system per square foot.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com